<DOC>
	<DOCNO>NCT01995721</DOCNO>
	<brief_summary>Recurrent respiratory papillomatosis child cause HPV 6,11 life threaten condition result surgical intervention . The mature disintegrating papilloma source subsequent HPV relapse immunization might slow even prevent ongoing process . After initial immunological ear-nose-throat ( ENT ) assessment child least 3 relapse patient history vaccinate 4-valent HPV vaccine accord follow schedule : 0. , 2. , 6. month . It follow immunological 3 ENT examination assess response vaccination .</brief_summary>
	<brief_title>4-valent HPV Vaccine Treat Recurrent Respiratory Papillomatosis Children</brief_title>
	<detailed_description>1 . Enrollment - ear-nose-throat ( ENT ) examination + oesophagoscopy - immunological assessment - assessment select humoral ( antibody ) - cellular immune response parameter ( INF gamma granzyme B testing ) - vitro vivo stimulation PMBCs HPV-4 vaccine 2 . Immunization 4-valent HPV vaccine 0,2,6 month 3 . Follow - 1 month 3rd vaccine dose - immunological assessment ( test enrollment phase ) - 6 , 12 18 month 3rd vaccine dose - ENT + oesophagoscopy</detailed_description>
	<mesh_term>Papilloma</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Papillomavirus Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>respiratory papillomatosis least 3 relapse patient history HPV 6 and/or 11 positive papilloma able mount neutralize antibody chronic underlying condition HPV type antibody response</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>recurrent respiratory papillomatosis</keyword>
	<keyword>human papillomavirus</keyword>
	<keyword>vaccine</keyword>
	<keyword>treatment</keyword>
	<keyword>immunology</keyword>
	<keyword>relapse</keyword>
</DOC>